Redcare Pharmacy Second Quarter 2025 Earnings: EPS: €0.46 (vs €0.21 loss in 2Q 2024)

Redcare Pharmacy (ETR:RDC) Second Quarter 2025 Results

Key Financial Results

• Revenue: €709.2m (up 27% from 2Q 2024).
• Net income: €9.35m (up from €4.27m loss in 2Q 2024).
• Profit margin: 1.3% (up from net loss in 2Q 2024). The move to profitability was driven by higher revenue.
• EPS: €0.46 (up from €0.21 loss in 2Q 2024).

This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality.

All figures shown in the chart above are for the trailing 12 month (TTM) period

Redcare Pharmacy Earnings Insights

Looking ahead, revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 4.8% growth forecast for the Consumer Retailing industry in Europe.

Performance of the market in Germany.

The company's share price is broadly unchanged from a week ago.

Risk Analysis

Be aware that Redcare Pharmacy is showing 1 warning sign in our investment analysis that you should know about...

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.